Invest now
Dr Reddy's Laboratories Profit & Loss Annual
BSE: 500124 | NSE: DRREDDY | ISIN: INE089A01031 | Sector: Biotechnology & Drugs1,194.15 -7.85 (-0.65%)Updated : 17 Aug 2026
Research on
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Operating Expense | 29,305.50 | 25,800.50 | 21,548.00 | 19,449.80 |
| Other Net | 318.70 | 190.80 | 234.20 | 628.90 |
| Diluted Weighted Average Shares | 83.33 | 83.42 | 83.35 | 83.19 |
| Gain( Loss)on Saleof Assets | 254.70 | 151.20 | 90.00 | -121.10 |
| Depreciation/ Amortization | 2,058.90 | 1,703.70 | 1,470.00 | 1,250.20 |
| Operating Income | 4,394.70 | 6,843.40 | 6,463.10 | 5,219.90 |
| Net Income | 4,196.00 | 5,655.10 | 5,577.90 | 4,507.30 |
| Income Availableto Com Excl Extra Ord | 4,196.00 | 5,655.10 | 5,577.90 | 4,507.30 |
| Other Operating Expenses Total | -0.10 | - | - | - |
| Net Income Before Taxes | 5,392.70 | 7,679.50 | 7,201.00 | 6,048.50 |
| Minority Interest | 38.40 | -70.10 | 0.00 | 0.00 |
| Net Income After Taxes | 4,157.60 | 5,725.20 | 5,577.90 | 4,507.30 |
| Income Availableto Com Incl Extra Ord | 4,196.00 | 5,655.10 | 5,577.90 | 4,507.30 |
| Costof Revenue Total | 13,036.30 | 10,783.40 | 8,939.80 | 8,304.80 |
| Gross Profit | 20,663.90 | 21,860.50 | 19,071.30 | 16,364.90 |
| Interest Inc( Exp) Net- Non- Op Total | 424.60 | 494.10 | 413.70 | 320.80 |
| Unusual Expense( Income) | 351.80 | 169.30 | 0.30 | 69.90 |
| Diluted Net Income | 4,196.00 | 5,655.10 | 5,577.90 | 4,507.30 |
| DPS- Common Stock Primary Issue | 8.00 | 8.00 | 8.00 | 8.00 |
| Provisionfor Income Taxes | 1,235.10 | 1,954.30 | 1,623.10 | 1,541.20 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 4,196.00 | 5,655.10 | 5,577.90 | 4,507.30 |
| Total Revenue | 33,700.20 | 32,643.90 | 28,011.10 | 24,669.70 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 33,700.20 | 32,643.90 | 28,011.10 | 24,669.70 |
| Selling/ General/ Admin Expenses Total | 11,787.70 | 10,756.00 | 9,202.60 | 8,204.80 |
| Diluted Normalized EPS | 51.25 | 67.95 | 66.08 | 55.89 |
| Research Development | 2,070.90 | 2,388.10 | 1,935.30 | 1,620.10 |
| Diluted EPS Excluding Extra Ord Items | 50.35 | 67.79 | 66.92 | 54.18 |
*All figures in crores except per share values
Dr Reddy's Laboratories Quick Links
Dr Reddy's Laboratories Dividend Dr Reddy's Laboratories Bonus Dr Reddy's Laboratories News Dr Reddy's Laboratories AGM Dr Reddy's Laboratories Rights Dr Reddy's Laboratories Splits Dr Reddy's Laboratories Board Meetings Dr Reddy's Laboratories Key Metrics Dr Reddy's Laboratories Shareholdings Dr Reddy's Laboratories Balance Sheet Dr Reddy's Laboratories Cashflow Dr Reddy's Laboratories Q1 Results Dr Reddy's Laboratories Q2 Results Dr Reddy's Laboratories Q3 Results Dr Reddy's Laboratories Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
5,098.20+155.20(3.14%)
1,102.85+20.85(1.93%)
2,024.95+23.05(1.15%)
1,072.00-24.05 (-2.19%)
310.50-4.95 (-1.57%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.